Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROSHARES TRUST (ZBIO) Current Leases: 2023-2024

Historic Current Leases for Zenas BioPharma (ZBIO) over the last 2 years, with Dec 2024 value amounting to $785,000.

  • Zenas BioPharma's Current Leases rose 60.94% to $618,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $618,000, marking a year-over-year increase of 60.94%. This contributed to the annual value of $785,000 for FY2024, which is 41.19% up from last year.
  • Zenas BioPharma's Current Leases amounted to $785,000 in FY2024, which was up 41.19% from $556,000 recorded in FY2023.
  • In the past 5 years, Zenas BioPharma's Current Leases ranged from a high of $785,000 in FY2024 and a low of $556,000 during FY2023.
  • Over the past 2 years, Zenas BioPharma's median Current Leases value was $670,500 (recorded in 2023), while the average stood at $670,500.
  • Data for Zenas BioPharma's Current Leases shows a peak YoY soared of 41.19% (in 2024) over the last 5 years.
  • Over the past 2 years, Zenas BioPharma's Current Leases (Yearly) stood at $556,000 in 2023, then skyrocketed by 41.19% to $785,000 in 2024.